Am I considered to have heart failure given a ejection fraction of 63% and mild concentric left ventricular hypertrophy?

Having an EF of 63% with Mild Concentric LVH Does NOT Automatically Mean You Have Heart Failure

You are not considered to have heart failure based solely on an ejection fraction of 63% and mild concentric left ventricular hypertrophy. Heart failure is a clinical diagnosis that requires symptoms (shortness of breath, fatigue, leg swelling) or signs of congestion, not just structural abnormalities on imaging 1, 2.

Understanding the Diagnosis of Heart Failure

Heart failure with preserved ejection fraction (HFpEF) requires three essential components 2:

1. Clinical symptoms/signs of heart failure (dyspnea, fatigue, edema, pulmonary congestion)
2. LVEF ≥50% (your 63% qualifies)
3. Objective evidence of either:
   • Elevated natriuretic peptides (BNP or NT-proBNP), OR
   • Documented cardiogenic congestion

Your structural findings alone—the mild LVH and preserved EF—represent cardiac remodeling but not necessarily heart failure. Many people with hypertension develop concentric LVH as an adaptive response without ever developing symptomatic heart failure 3.

What Your Findings Actually Mean

Your echocardiogram shows:

• Normal systolic function (EF 63% is well above the 50% threshold)
• Mild concentric remodeling (early hypertensive heart disease pattern)

This pattern is extremely common in hypertension and represents a risk factor for future HFpEF rather than established heart failure 4, 5. Left ventricular hypertrophy is the most common structural abnormality associated with HFpEF, but its presence doesn't confirm the diagnosis 5.

Important Caveat About LVH Measurement

2D echocardiography significantly overestimates concentric hypertrophy in up to 68% of cases compared to 3D imaging 6. If your "mild" LVH was measured by standard 2D echo, you may have even less hypertrophy than reported—or possibly just concentric remodeling without true hypertrophy.

What You Need to Establish a Diagnosis

To determine if you have HFpEF, your clinician must assess:

Clinical criteria:

• Do you have exertional dyspnea, fatigue, or exercise intolerance?
• Any signs of fluid retention (leg swelling, lung congestion)?
• Check natriuretic peptides (BNP or NT-proBNP levels)

Echocardiographic diastolic function:

• E/e' ratio (elevated suggests increased filling pressures)
• Left atrial enlargement (LA volume >37.5 mL is highly predictive of HFpEF) 4
• Evidence of diastolic dysfunction

Risk stratification:

• The H2FPEF score can help determine probability: Heavy (obesity), Hypertensive, atrial Fibrillation, Pulmonary hypertension, Elder age (>60), elevated Filling pressures 2, 4
• Scores <2 = low probability; 2-5 = intermediate (may need stress testing); ≥6 = high probability

The Bottom Line

If you have no symptoms and normal natriuretic peptides, you do not have heart failure—you have hypertensive heart disease with structural remodeling. This is a critical distinction because:

• You don't need heart failure medications (SGLT2 inhibitors, etc.) at this stage
• Your focus should be aggressive blood pressure control to prevent progression 7
• You need monitoring for symptom development and periodic reassessment

However, if you DO have exertional dyspnea or other HF symptoms, then further evaluation with natriuretic peptides, comprehensive diastolic function assessment, and possibly exercise testing is warranted to confirm or exclude HFpEF 1, 2.

Your mild LVH places you at increased risk for developing HFpEF in the future, making blood pressure optimization and cardiovascular risk factor management essential preventive strategies 5, 7.